These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24576987)

  • 21. Varenicline precipitating psychosis in a patient with no previous psychiatric history: a case report of a Spanish patient who was later diagnosed with paranoid personality disorder.
    Forcen FE; Martinez FL; Moya AM
    Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):221-3. PubMed ID: 22182460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varenicline-induced grand mal seizure.
    Serafini A; Crespel A; Velizara R; Gelisse P
    Epileptic Disord; 2010 Dec; 12(4):338. PubMed ID: 21287775
    [No Abstract]   [Full Text] [Related]  

  • 23. Varenicline and pheochromocytoma.
    Hukkanen J; Ukkola O; Benowitz NL
    Ann Intern Med; 2010 Mar; 152(5):335-6. PubMed ID: 20194248
    [No Abstract]   [Full Text] [Related]  

  • 24. Varenicline (Chantix) warnings: risk versus benefit.
    Med Lett Drugs Ther; 2008 Jul; 50(1290):53. PubMed ID: 18617873
    [No Abstract]   [Full Text] [Related]  

  • 25. More evidence that varenicline harms the heart.
    Harv Ment Health Lett; 2011 Oct; 28(4):7. PubMed ID: 22125830
    [No Abstract]   [Full Text] [Related]  

  • 26. Varenicline: the risks of over-the-counter sales in Brazil.
    Zaparoli JX; Galduróz JC
    Braz J Psychiatry; 2013; 35(4):442-3. PubMed ID: 24402222
    [No Abstract]   [Full Text] [Related]  

  • 27. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effectiveness and safety of varenicline for smoking cessation].
    Christalla P; Dewenter M; El-Armouche A
    Dtsch Med Wochenschr; 2012 May; 137(18):940-4. PubMed ID: 22492478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commentary on "The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey" by Enger et al.
    Dal Pan GJ
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):716-8. PubMed ID: 23661561
    [No Abstract]   [Full Text] [Related]  

  • 30. Varenicline: the French experience after 6 months.
    Prescrire Int; 2009 Feb; 18(99):25. PubMed ID: 19396936
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of varenicline versus bupropion and risk of psychiatric adverse events.
    Pasternak B; Svanström H; Hviid A
    Addiction; 2013 Jul; 108(7):1336-43. PubMed ID: 23445269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey.
    Enger C; Younus M; Petronis KR; Mo J; Gately R; Seeger JD
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):705-15. PubMed ID: 23349095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Varenicline for smoking cessation.
    Harrison-Woolrych M
    BMJ; 2012 Nov; 345():e7547. PubMed ID: 23138037
    [No Abstract]   [Full Text] [Related]  

  • 34. Adverse neuropsychiatric events associated with varenicline use in veterans: a case series.
    Cantrell M; Argo T; Haak L; Janney L
    Issues Ment Health Nurs; 2012 Oct; 33(10):665-9. PubMed ID: 23017042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varenicline and the evaluation of neuropsychiatric adverse events in smokers.
    O'Malley SS
    Biol Psychiatry; 2011 Jun; 69(11):1017-8. PubMed ID: 21550436
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies linking smoking-cessation drug with suicide risk spark concerns.
    Kuehn BM
    JAMA; 2009 Mar; 301(10):1007-8. PubMed ID: 19278936
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of nicotine dependence with Chantix (varenicline).
    Rankin KV; Jones DL
    Tex Dent J; 2011 May; 128(5):457-61. PubMed ID: 21834368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers.
    McColl SL; Burstein AH; Reeves KR; Billing CB; Stolar M; Sellers EM
    Clin Pharmacol Ther; 2008 Apr; 83(4):607-14. PubMed ID: 18288085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience of varenicline for smoking cessation.
    Jung JW; Jeon EJ; Kim JG; Yang SY; Choi JC; Shin JW; Park IW; Choi BW; Kim DK; Kim JY
    Clin Respir J; 2010 Oct; 4(4):215-21. PubMed ID: 20887344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varenicline for smoking cessation: a placebo-controlled, randomized study.
    Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
    Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.